Clinical trial
Viapaed Study In Children And Adolescents With Asthma
NCT00315744 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00315744 |
|---|---|
| Title | Viapaed Study In Children And Adolescents With Asthma |
| Official title | Steroid-sparing Management of the Salmeterol/Fluticasone 50/100µg b.i.d. Combination Compared to Fluticasone 200µg b.i.d. in Children and Adolescents With Moderate Asthma |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Salmeterol/fluticasone, Fluticasone propionate, Salbutamol |
| Enrollment | 285 |
| Start date | Nov 4, 2004 |
| Primary completion | Apr 12, 2007 |
| Completion | Apr 12, 2007 |
| First posted | Apr 19, 2006 |
| Last update posted | Oct 19, 2017 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: